Diaz Allene M. — SEC Form 4 filings

SEC reporting owner CIK 1773314. 11 Form 4 filings on record with FilingPulse; latest filed 2026-07-09.

Transaction summary — filings shown

Covers all 11 filings on record, filed 2024-06-12 to 2026-07-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
IONIS PHARMACEUTICALS INC (IONS)Director87 legs · 68,053 sh · $5,359,77218
Mersana Therapeutics, Inc. (MRSN)Director39

Form 4 filings — Diaz Allene M.

FiledFormIssuerReported transactionsSource
2026-07-094IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 10,111 @ $47.11 · Sale (S): 10,111 @ $85.42 · Option exercise (M): 10,111 (derivative) @ $0EDGAR
2026-07-064IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 5,369 (derivative) @ $0 · Grant/award (A): 2,301 (derivative) @ $0EDGAR
2026-03-054IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 10,321 @ $41.08 · Option exercise (M): 12,000 @ $38.06 · Option exercise (M): 18,000 @ $40.05 · Sale (S): 39,265 @ $79.11 · Sale (S): 14,608 @ $79.88 · Sale (S): 1,005 @ $80.80 · +3 moreEDGAR
2026-01-064Mersana Therapeutics, Inc. (MRSN)Code (U): 578 · Disposition to issuer (D): 2,460 (derivative) · Disposition to issuer (D): 1,571 (derivative) · Disposition to issuer (D): 416 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 734 (derivative) · +1 moreEDGAR
2025-08-264IONIS PHARMACEUTICALS INC (IONS)Sale (S): 1,427 @ $42.53EDGAR
2025-07-174IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 4,079 @ $0 · Option exercise (M): 4,079 (derivative) @ $0EDGAR
2025-07-024IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 11,518 (derivative) @ $0 · Grant/award (A): 5,220 (derivative) @ $0EDGAR
2025-06-134Mersana Therapeutics, Inc. (MRSN)Grant/award (A): 61,500 (derivative) @ $0EDGAR
2024-07-174IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 4,677 @ $0 · Sale (S): 900 @ $48.94 · Sale (S): 737 @ $50.17 · Option exercise (M): 4,677 (derivative) @ $0EDGAR
2024-07-034IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 10,111 (derivative) @ $0 · Grant/award (A): 4,079 (derivative) @ $0EDGAR
2024-06-124Mersana Therapeutics, Inc. (MRSN)Grant/award (A): 55,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1773314 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →